Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.